India's Cipla cuts prices of three cancer drugs
12 November 2012
Clinical gold-standard treatment for metastatic first-line HER2-positive breast cancer in 2015
5 February 2012
Sanofi facing generic Taxotere competition in USA; first biosimilar cleared in Australia
30 September 2010
Europe’s CHMP backs Sanofi Pasteur’s Humenza and GSK’s Votrient; gives opinions on other products
22 February 2010
Sanofi-Aventis 2009 EPS leaps 18% but slows in 4th quarter; in line with expectations
10 February 2010
Mylan confirms first-to-file patent challenge to Cephalon’s sleep-disorder drug Nuvigil
12 January 2010
Meeting highlights from Europe’s CHMP November 16-19, 2009
23 November 2009
FDA accuses Sanofi of using misleading article
15 May 2009
Sanofi relocates plant to Binjiang
22 April 2009
Provenge induces long-term immune responses
20 April 2009
Higher sales still do not cover Hybrigenics' costs
17 April 2009
Record sales for Sanofi Japan, says president
14 April 2009
Hybrigenics agrees trial details with FDA
23 March 2009
Thailand "threat" to USA over CL policy
16 March 2009
Thailand group fights EU-ASEAN FTA
2 March 2009
Hybrigenics' 2008 sales increase 22%
9 February 2009
Takeda drops Cell's GVAX after deaths
15 December 2008
AZ's HRPC drug yields 45% drop in death risk
8 December 2008
NICE recommends Roche's Tarceva as Taxotere alternative
1 December 2008
Sanofi withdraws new Taxotere use MAA
24 November 2008
Japan stock market week to Oct 27, 2008
3 November 2008
UPDATE: Roche offers discount to UK NHS for Tarceva
13 October 2008
Roche offers discount to NHS for Tarceva
13 October 2008
Thailand's new Health Minister will keep CLs
6 October 2008
Hybrigenics receives 1.4M-euro award from OSEO
15 September 2008
Japan stock market week to Sept 1, 2008
8 September 2008
Cell Genesys shares crash 70% after deaths in GVAX trial
1 September 2008
UPDATE: Thailand "will not end" compulsory licenses
1 September 2008
Apotex sued by Sanofi, settles with Pfizer
18 August 2008
Sanofi-Aventis' second-quarter 2008 results disappoint analysts, hit by weak US dollar
11 August 2008
Tavocept increases survival by 198 days
28 July 2008
Hybrigenics raises dosage in inecalcitol study
23 June 2008
Thai dispute over PReMA member for GPO board
5 May 2008
Sanofi-Aventis
5 May 2008
Sanofi restructures at Vitry, with job losses
7 April 2008
Foreign groups try to stop Thailand CL climbdown
3 March 2008
Thailand Health Ministry change could mean fewer CLs
18 February 2008
Cell Genesys' GVAX trial gets IDMC go ahead
21 January 2008
NeoPharm files IND for novel docetaxel delivery system
7 January 2008
Neoadjuvant Xeloda reduces breast tumor size in Ph II trial
24 December 2007
Novacea stops Ph III Asentar trial
12 November 2007
UPDATE: Thailand negotiations on drug prices continue
29 October 2007
CHMP recommends Taxotere SCCHN approval expansion
29 October 2007
Thailand negotiations on drug prices continue
29 October 2007
World Conference on Lung Cancer highlights important developments
17 September 2007
China's prostate cancer population to grow 238%
3 September 2007
Spectrum gets world rights to ortataxel
20 August 2007
Taxotere gets priority Japan review for mHRPC
18 June 2007
Satraplatin cuts progression in prostate cancer
11 June 2007
FDA halts talabostat trials on efficacy concerns
28 May 2007
Satraplatin delays pain progression to 66 weeks
28 May 2007
Taxotere's efficacy in prostate cancer shown
5 March 2007
Novacea's Asentar improves survival in AIPC
26 February 2007
AstraZeneca's R&D pipeline update reveals 120 NCEs and 25 LCM strategies in progress
12 February 2007
Update: Rumors say Sanofi to merge with B-MS
5 February 2007
Strong data for Sanofi's Taxotere in node (+) breast cancer
22 December 2006
Herceptin/Taxotere improve DF survival
22 December 2006
Stock Commentary - New York week to Nov 13, 2006
20 November 2006
Sanofi-Aventis gets EMEA ok for Taxotere in SCHN
13 November 2006
Generics, including Plavix, and govt cost-cutting hit Sanofi-Aventis' 3rd-qtr results
6 November 2006
UK's NICE OKs Sanofi's Taxotere
2 October 2006
YM Bio's tesmilifene trial gets IDSMB OK
4 September 2006
UK's NICE calls for beta blocker phase out
3 July 2006
Lilly's Alimta 'as effective as Taxotere'
12 June 2006
Good data on Sanofi's Eloxatin and Taxotere at ASCO
12 June 2006
FDA fast track for Cell Genesys' GVAX
15 May 2006
Stock Commentary - Europe - week to April 3, 2006
10 April 2006
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
